HK Stock Market Move | PONY-W(02026) opened more than 5% higher in the third quarter with a 72% year-on-year growth in total revenue. Profit from city-level single bike operations turned positive.
Xiaoma Intelligen-W (02026) opened more than 5% higher, rising by 5.61% as of press time to 101.6 Hong Kong dollars, with a turnover of 1.7983 million Hong Kong dollars.
PONY-W(02026) opened more than 5% higher, rising 5.61% to 101.6 Hong Kong dollars with a trading volume of 1.7983 million Hong Kong dollars as of the time of writing.
On the news front, on November 25th, Pony.ai released its third-quarter financial report for 2025, announcing that its seventh-generation Robotaxi in Guangzhou had achieved single-car profitability, and the company would surpass its goal of 1,000 Robotaxis ahead of schedule, expanding to over 3,000 by the end of 2026. The company generated total revenue of 181 million RMB in the third quarter, a year-on-year increase of 72%, marking three consecutive quarters of revenue growth. Revenue from the Robotaxi business in the third quarter reached 47.7 million RMB, an 89.5% year-on-year increase, with passenger fare revenue seeing a more than 200% increase.
As of the end of the quarter, the company had a total of 4.184 billion RMB in cash and cash equivalents, short-term investments, restricted cash, and long-term debt-based financial products; with at least 6 billion RMB in additional cash raised since its listing on the Hong Kong Stock Exchange, the funds will be used to accelerate mass production and commercialization of self-driving vehicles, technology research and development, and market expansion. Through partnerships with global travel companies such as Uber and ComfortDelGro, Pony.ai's Robotaxi business deployment and fleet testing have already covered 8 countries.
Related Articles
.png)
From summit to win-win! FANGZHOU HEALTH (06086), VIGONVITA-B (02630) deepen strategic cooperation in the field of "AI + chronic disease management", jointly building the future of intelligent health industry.

HK Stock Market Move | CSTONE PHARMA-B (02616) rose more than 5%. The European Commission has approved a new indication for Sujigilibab.

HK Stock Market Move | HENLIUS (02696) rises more than 5%, multiple solid tumor pipelines will debut at the ESMO ASIA 2025 conference.
From summit to win-win! FANGZHOU HEALTH (06086), VIGONVITA-B (02630) deepen strategic cooperation in the field of "AI + chronic disease management", jointly building the future of intelligent health industry.
.png)
HK Stock Market Move | CSTONE PHARMA-B (02616) rose more than 5%. The European Commission has approved a new indication for Sujigilibab.

HK Stock Market Move | HENLIUS (02696) rises more than 5%, multiple solid tumor pipelines will debut at the ESMO ASIA 2025 conference.

RECOMMEND

Foreign Brands “Take On Chinese Names”: Starbucks And Burger King Change Hands As Chinese Capital’s Localization Scalpel Rewrites Global Rules
25/11/2025

Riding The Momentum Of Gemini 3, “Google Chain” Challenges “Nvidia Chain,” Reshaping The Ai Trading Landscape
25/11/2025

Silver Economy Accelerates As Personal Pension System Marks Three Years — Structural Changes Emerging
25/11/2025


